Display options
Share it on

World J Hepatol. 2015 Mar 27;7(3):593-9. doi: 10.4254/wjh.v7.i3.593.

Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy.

World journal of hepatology

Koji Miyanishi, Toshifumi Hoki, Shingo Tanaka, Junji Kato

Affiliations

  1. Koji Miyanishi, Toshifumi Hoki, Shingo Tanaka, Junji Kato, Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.

PMID: 25848483 PMCID: PMC4381182 DOI: 10.4254/wjh.v7.i3.593

Abstract

Oxidative stress has been investigated in the context of alcoholic liver injury for many years and shown to be a causal factor of chronic hepatitis C (CHC), nonalcoholic steatohepatitis (NASH), drug-induced liver injury, Wilson's disease, and hemochromatosis. In CHC, it has been demonstrated that oxidative stress plays an important role in hepatocarcinogenesis. In cases with persistent hepatitis due to failure of hepatitis C virus eradication, or chronic liver disease, such as NASH, the treatment of which remains unestablished, it is important to reduce serum alanine aminotransferase levels and prevent liver fibrosis and development of hepatocellular carcinoma. This also suggests the importance of antioxidant therapy. Among treatment options where it would be expected that anti-inflammatory activity plays a role in their confirmed efficacy for chronic hepatitis, iron depletion therapy, glycyrrhizin, ursodeoxycholic acid, Sho-Saiko-To, and vitamin E can all be considered antioxidant therapies. To date, however, the ability of these treatments to prevent cancer has been confirmed only in CHC. Nevertheless, anti-inflammatory and anti-fibrotic effects have been demonstrated in other liver diseases and these therapies may potentially be effective for cancer prevention.

Keywords: Antioxidant therapy; Chronic hepatitis; Hepatocellular carcinoma; Iron depletion therapy; Prevention

References

  1. J Clin Invest. 1996 Aug 15;98(4):923-9 - PubMed
  2. J Pediatr Gastroenterol Nutr. 2004 Jan;38(1):48-55 - PubMed
  3. Free Radic Biol Med. 1997;22(1-2):287-305 - PubMed
  4. Cancer. 1997 Apr 15;79(8):1494-500 - PubMed
  5. Hepatology. 1991 Feb;13(2):339-44 - PubMed
  6. Hepatology. 1994 Sep;20(3):558-64 - PubMed
  7. Am J Gastroenterol. 2001 Aug;96(8):2432-7 - PubMed
  8. Hepatology. 1999 Jan;29(1):149-60 - PubMed
  9. Carcinogenesis. 1999 Jan;20(1):59-63 - PubMed
  10. Hepatology. 2002 May;35(5):1125-33 - PubMed
  11. Gastroenterol Jpn. 1989 Dec;24(6):715-9 - PubMed
  12. Gastroenterology. 1993 Jun;104(6):1736-44 - PubMed
  13. J Gastroenterol Hepatol. 1999 Nov;14(11):1093-9 - PubMed
  14. Biol Pharm Bull. 1993 Aug;16(8):782-6 - PubMed
  15. Carcinogenesis. 1990 Sep;11(9):1447-50 - PubMed
  16. J Pediatr. 2000 Jun;136(6):734-8 - PubMed
  17. Aliment Pharmacol Ther. 2013 Apr;37(7):720-9 - PubMed
  18. Hepatol Res. 2006 Dec;36(4):315-21 - PubMed
  19. Gastroenterology. 2008 Jan;134(1):226-38 - PubMed
  20. Hepatology. 2010 Jun;51(6):1972-8 - PubMed
  21. Gastroenterology. 2004 Nov;127(5 Suppl 1):S79-86 - PubMed
  22. Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2196-201 - PubMed
  23. Recent Results Cancer Res. 2011;188:85-99 - PubMed
  24. Hepatology. 1993 Oct;18(4):874-80 - PubMed
  25. J Hepatol. 1993 Nov;19(3):459-64 - PubMed
  26. J Biol Chem. 1992 Jan 5;267(1):166-72 - PubMed
  27. J Biol Chem. 1986 Jul 5;261(19):8708-11 - PubMed
  28. World J Gastroenterol. 2014 Mar 21;20(11):3002-10 - PubMed
  29. Biomed Res Int. 2014;2014:872139 - PubMed
  30. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):164-9 - PubMed
  31. Int J Vitam Nutr Res. 2001 Sep;71(5):261-7 - PubMed
  32. Gastroenterology. 1998 Feb;114(2):311-8 - PubMed
  33. Hepatol Res. 2007 Sep;37 Suppl 2:S287-93 - PubMed
  34. Free Radic Biol Med. 1999 Aug;27(3-4):478-82 - PubMed
  35. Am J Gastroenterol. 2003 Nov;98(11):2485-90 - PubMed
  36. N Engl J Med. 2010 May 6;362(18):1675-85 - PubMed
  37. Hepatology. 2003 Aug;38(2):413-9 - PubMed
  38. Free Radic Biol Med. 2011 Sep 1;51(5):1000-13 - PubMed
  39. Gut. 1996 Sep;39(3):475-8 - PubMed
  40. Hepatology. 1992 Aug;16(2):358-64 - PubMed
  41. Am J Gastroenterol. 2007 Jun;102(6):1251-8 - PubMed
  42. Biochem Biophys Res Commun. 1999 Sep 24;263(2):537-42 - PubMed
  43. Free Radic Res. 2003 Jul;37(7):781-5 - PubMed
  44. Aliment Pharmacol Ther. 2001 Oct;15(10):1667-72 - PubMed
  45. J Gastroenterol. 2007 Oct;42(10):830-6 - PubMed
  46. Q J Med. 1976 Oct;45(180):611-23 - PubMed
  47. Gastroenterology. 1998 Apr;114(4):842-5 - PubMed
  48. Am J Gastroenterol. 1994 Jul;89(7):986-8 - PubMed
  49. Am J Physiol. 1988 Feb;254(2 Pt 1):G232-41 - PubMed
  50. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):424-32 - PubMed
  51. Planta Med. 1984 Aug;50(4):298-302 - PubMed
  52. Clin Gastroenterol Hepatol. 2006 Dec;4(12):1537-43 - PubMed
  53. Dig Dis Sci. 2004 Jun;49(6):1012-5 - PubMed
  54. Dig Dis Sci. 1985 Jul;30(7):642-9 - PubMed
  55. Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:61-3 - PubMed
  56. Gastroenterology. 2002 Apr;122(4):931-9 - PubMed
  57. Hepatology. 1999 Jun;29(6):1884-92 - PubMed
  58. Dig Dis Sci. 1996 Dec;41(12 Suppl):49S-55S - PubMed
  59. Gastroenterology. 1997 Oct;113(4):1069-73 - PubMed
  60. J Hepatol. 1995 Apr;22(4):449-56 - PubMed
  61. Cancer. 1995 Sep 1;76(5):743-9 - PubMed
  62. Cancer Res. 2001 Dec 15;61(24):8697-702 - PubMed
  63. Free Radic Res. 1997 Dec;27(6):599-605 - PubMed

Publication Types